Sandra Brooks1, Barbara D Friedes2, Frances Northington3, Ernest Graham4, Aylin Tekes5, Vera J Burton6, Gwendolyn Gerner6, Jie Zhu3, Raul Chavez-Valdez3, Dhananjay Vaidya7, Allen D Everett3. 1. Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA. sbrook36@jhmi.edu. 2. Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Departments of Maternal-Fetal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 5. Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 6. Kennedy-Krieger Institute, Baltimore, MD, USA. 7. Department of Intermal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract
BACKGROUND: To determine the association of gestational age (GA) and day of life (DOL) with the circulating serum concentration of six brain injury-associated biomarkers in non-brain injured neonates born between 23 and 41 weeks' GA. METHODS: In a multicenter prospective observational cohort study, serum CNS-insult, inflammatory and trophic proteins concentrations were measured daily in the first 7 DOL. RESULTS: Overall, 3232 serum samples were analyzed from 745 enrollees, median GA 32.3 weeks. BDNF increased 3.7% and IL-8 increased 8.9% each week of gestation. VEGF, IL-6, and IL-10 showed no relationship with GA. VEGF increased 10.8% and IL-8 18.9%, each DOL. IL-6 decreased by 15.8% each DOL. IL-10 decreased by 81.4% each DOL for DOL 0-3. BDNF did not change with DOL. Only 49.67% of samples had detectable GFAP and 33.15% had detectable NRGN. The odds of having detectable GFAP and NRGN increased by 53% and 11%, respectively, each week after 36 weeks' GA. The odds of having detectable GFAP and NRGN decreased by 15% and 8%, respectively, each DOL. CONCLUSIONS: BDNF and IL-8 serum concentrations vary with GA. VEGF and interleukin concentrations are dynamic in the first week of life, suggesting circulating levels should be adjusted for GA and DOL for clinically relevant assessment of brain injury. IMPACT: Normative data of six brain injury-related biomarkers is being proposed. When interpreting serum concentrations of brain injury biomarkers, it is key to adjust for gestational age at birth and day of life during the first week to correctly assess for clinical brain injury in neonates. Variation in levels of some biomarkers may be related to gestational and postnatal age and not necessarily pathology.
BACKGROUND: To determine the association of gestational age (GA) and day of life (DOL) with the circulating serum concentration of six brain injury-associated biomarkers in non-brain injured neonates born between 23 and 41 weeks' GA. METHODS: In a multicenter prospective observational cohort study, serum CNS-insult, inflammatory and trophic proteins concentrations were measured daily in the first 7 DOL. RESULTS: Overall, 3232 serum samples were analyzed from 745 enrollees, median GA 32.3 weeks. BDNF increased 3.7% and IL-8 increased 8.9% each week of gestation. VEGF, IL-6, and IL-10 showed no relationship with GA. VEGF increased 10.8% and IL-8 18.9%, each DOL. IL-6 decreased by 15.8% each DOL. IL-10 decreased by 81.4% each DOL for DOL 0-3. BDNF did not change with DOL. Only 49.67% of samples had detectable GFAP and 33.15% had detectable NRGN. The odds of having detectable GFAP and NRGN increased by 53% and 11%, respectively, each week after 36 weeks' GA. The odds of having detectable GFAP and NRGN decreased by 15% and 8%, respectively, each DOL. CONCLUSIONS: BDNF and IL-8 serum concentrations vary with GA. VEGF and interleukin concentrations are dynamic in the first week of life, suggesting circulating levels should be adjusted for GA and DOL for clinically relevant assessment of brain injury. IMPACT: Normative data of six brain injury-related biomarkers is being proposed. When interpreting serum concentrations of brain injury biomarkers, it is key to adjust for gestational age at birth and day of life during the first week to correctly assess for clinical brain injury in neonates. Variation in levels of some biomarkers may be related to gestational and postnatal age and not necessarily pathology.
Authors: Eric M Chin; Srishti Jayakumar; Ezequiel Ramos; Gwendolyn Gerner; Bruno P Soares; Elizabeth Cristofalo; Mary Leppert; Marilee Allen; Charla Parkinson; Michael Johnston; Frances Northington; Vera Joanna Burton Journal: Dev Neurosci Date: 2019-06-05 Impact factor: 2.984
Authors: Gwendolyn J Gerner; Eric I Newman; V Joanna Burton; Brenton Roman; Elizabeth A Cristofalo; Mary Leppert; Michael V Johnston; Frances J Northington; Thierry A G M Huisman; Andrea Poretti Journal: J Child Neurol Date: 2019-05-09 Impact factor: 1.987
Authors: Eric M Graham; Renee' H Martin; Andrew M Atz; Kasey Hamlin-Smith; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Allen D Everett Journal: J Thorac Cardiovasc Surg Date: 2019-01-23 Impact factor: 5.209
Authors: Anders B Klein; Rebecca Williamson; Martin A Santini; Christoffer Clemmensen; Anders Ettrup; Maribel Rios; Gitte M Knudsen; Susana Aznar Journal: Int J Neuropsychopharmacol Date: 2010-07-07 Impact factor: 5.176
Authors: Seetha Shankaran; Abbot R Laptook; Richard A Ehrenkranz; Jon E Tyson; Scott A McDonald; Edward F Donovan; Avroy A Fanaroff; W Kenneth Poole; Linda L Wright; Rosemary D Higgins; Neil N Finer; Waldemar A Carlo; Shahnaz Duara; William Oh; C Michael Cotten; David K Stevenson; Barbara J Stoll; James A Lemons; Ronnie Guillet; Alan H Jobe Journal: N Engl J Med Date: 2005-10-13 Impact factor: 91.245
Authors: Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Noppadol Chaiyasit; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim Journal: J Perinat Med Date: 2016-01 Impact factor: 1.901
Authors: An N Massaro; Andreas Jeromin; Nadja Kadom; Gilbert Vezina; Ronald L Hayes; Kevin K W Wang; Jackson Streeter; Michael V Johnston Journal: Pediatr Crit Care Med Date: 2013-03 Impact factor: 3.624
Authors: Kristin Leifsdottir; Kerstin Jost; Veronica Siljehav; Eric P Thelin; Philipp Lassarén; Peter Nilsson; Ásgeir Haraldsson; Staffan Eksborg; Eric Herlenius Journal: Front Pediatr Date: 2022-07-19 Impact factor: 3.569